Single-Photon Emission Computed Tomography/Computed Tomography in Lung Cancer and Malignant Lymphoma

Seminars in Nuclear Medicine

Volumn 36, Issue 4, 2006, Pages 275-285

  Schillaci, Orazio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEPREOTIDE TC 99M; GALLIUM 67; GALLIUM CITRATE GA 67; IODINE 131; PENTETREOTIDE IN 111; RITUXIMAB; TECHNETIUM 99M; TETROFOSMIN; YTTRIUM 90;

CANCER GRADING; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DOSIMETRY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG UPTAKE; HUMAN; LUNG CANCER; LYMPHOMA; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EQUIPMENT DESIGN; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG NEOPLASMS; LYMPHOMA; SUBTRACTION TECHNIQUE; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748205945     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2006.05.003     Document Type: Review

References (97)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Swerdlow A.J. Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging 30 suppl 1 (2003) S3-S12
3. Buscombe J.R., and Bombardieri E. Imaging cancer using single photon techniques. Q J Nucl Med Mol Imaging 49 (2005) 121-131
4. Schillaci O., and Simonetti G. Fusion imaging in nuclear medicine-applications of dual-modality systems in oncology. Cancer Biother Radiopharm 19 (2004) 1-10
5. Schomacker K., and Schicha H. Use of myocardial imaging agents for tumour diagnosis-a success story?. Eur J Nucl Med 27 (2000) 1845-1863
6. Maublant J., Zhang Z., Rapp M., et al. In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med 34 (1993) 1949-1952
7. Scopinaro F., Schillaci O., Scarpini M., et al. Technetium-99m sestamibi: an indicator of breast cancer invasiveness. Eur J Nucl Med 21 (1994) 984-987
8. Arbab A.S., Koizumi K., Toyama K., et al. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 37 (1996) 1551-1556
9. Arbab A.S., Koizumi K., Toyama K., et al. Ion transport systems in the uptake of 99Tcm-tetrofosmin, 99Tcm-MIBI and 201Tl in a tumour cell line. Nucl Med Commun 1997 (1997) 235-240
10. Hendrikse N.H., Franssen E.J., van der Graaf W.T., et al. Visualization of multidrug resistance in vivo. Eur J Nucl Med 26 (1999) 283-293
11. Perek N., and Denoyer D. The multidrug resistance mechanisms and their interactions with the radiopharmaceutical probes used for an in vivo detection. Curr Drug Metab 3 (2002) 97-113
12. Edwards C.L., and Hayes R.L. Tumor scanning with 67Ga citrate. J Nucl Med 10 (1969) 103-105
13. Larson S.M. Mechanisms of localization of gallium-67 in tumors. Semin Nucl Med 8 (1978) 193-203
14. Nejmeddine F., Caillat-Vigneron N., Escaig F., et al. Mechanism involved in gallium-67 (Ga-67) uptake by human lymphoid cell lines. Cell Mol Biol 44 (1998) 1215-1220
15. Even-Sapir E., and Israel O. Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma. Eur J Nucl Med Mol Imaging 30 suppl 1 (2003) S65-S81
16. Krenning E.P., Kwekkeboom D.J., Bakker W.H., et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and[123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20 (1993) 716-731
17. Gotthardt M., Behe M.P., Alfke H., et al. Imaging lung tumors with peptide-based radioligands. Clin Lung Cancer 5 (2003) 119-124
18. Machac J., Krynyckyi B., and Kim C. Peptide and antibody imaging in lung cancer. Semin Nucl Med 32 (2002) 276-292
19. Samoszuk M.K., Anderson A.L., Ramzi E., et al. Radioimmunodetection of Hodgkin's disease and non-Hodgkin's lymphomas with monoclonal antibody to eosinophil peroxidase. J Nucl Med 34 (1993) 1246-1253
20. Zuckier L.S., and DeNardo G.L. Trials and tribulations: oncological antibody imaging comes to the fore. Semin Nucl Med 25 (1997) 10-29
21. Maisey M.N., Hawkes D.J., and Lukswiecki-Vydelingum. AM synergistic imaging. Eur J Nucl Med 19 (1992) 1002-1005
22. Lucignani G. SPET: sustainable, powerful, effective, timely in vivo molecular imaging. (editorial). Q J Nucl Med Mol Imaging 49 (2005) 117-120
23. Schillaci O. Functional-anatomical image fusion in neuroendocrine tumors. Cancer Biother Radiopharm 19 (2004) 129-134
24. Kramer E.L., and Noz M.E. CT-SPECT fusion for analysis of radiolabeled antibodies: applications in gastrointestinal and lung carcinoma. Nucl Med Biol 18 (1991) 27-42
25. Israel O., Keidar Z., Iosilevsky G., et al. The fusion of anatomic and physiologic imaging in the management of patients with cancer. Semin Nucl Med 31 (2001) 191-205
26. Shreve P.D. Adding structure to function. J Nucl Med 41 (2000) 1380-1382
27. Maintz J.B., and Viergever M.A. A survey of medical imaging registration. Med Image Anal 2 (1998) 1-36
28. Hutton B.F., Braun M., Thurfjell L., et al. Image registration: an essential tool for nuclear medicine. Eur J Nucl Med Mol Imaging 29 (2002) 559-577
29. Pelizzari C.A., Chen G.T., Spelbring D.R., et al. Accurate registration of CT, PET, and/or MR images of the brain. J Comput Assist Tomogr 13 (1989) 20-26
30. Dayatzikos C. Spatial normalization of 3-D brain images using deformable models. J Comput Assist Tomogr 20 (1996) 656-665
31. Pietrzyk U., Herholz K., and Weiss W.D. Three-dimensional alignment of functional and morphological tomograms. J Comput Assist Tomogr 14 (1990) 51-59
32. Perault C., Schvartz C., Wampach H., et al. Thoracic and abdominal SPECT/CT image fusion without external markers in endocrine carcinomas. J Nucl Med 38 (1997) 1234-1242
33. Hawkes D.J. Algorithms for radiological image registration and their clinical applications. J Anat 193 (1998) 347-361
34. Little J.A., and Hawkes D.J. The registration of multiple medical images acquired from a single subject: why, how, what next?. Stat Methods Med Res 6 (1997) 239-265
35. Treves S.T., Mitchell K.D., and Habboush I.H. Three-dimensional image alignment, registration and fusion. Q J Nucl Med 42 (1998) 83-92
36. Audette M.A., Ferrie F.P., and Peters T.M. An alghoritmic overview of surface registration techniques for medical imaging. Med Image Anal 4 (2000) 201-217
37. Cook G.J.R., and Ott R.J. Dual-modality imaging. Eur Radiol 11 (2001) 1857-1858
38. von Schulthess G.K., and Pelc N.J. Integrated-modality imaging: the best of both words. (editorial). Acad Radiol 9 (2002) 1241-1244
39. Bocher M., Balan A., Krausz Y., et al. Gamma camera-mounted anatomical X-ray tomography: technology, system characteristics and first images. Eur J Nucl Med 27 (2000) 619-627
40. Schillaci O. Hybrid SPECT/CT: a new era for SPECT imaging?. (editorial). Eur J Nucl Med Mol Imaging 32 (2005) 521-524
41. Kneifel S. Radiation dose and radiation protection. In: von Schulthess G.K. (Ed). Clinical Molecular Anatomic Imaging (2003), Lippincott Williams & Wilkins, Philadelphia 68-71
42. Katyal S., Kramer E.L., Noz M.E., et al. Fusion of immunoscintigraphy single photon emission computed tomography (SPECT) with CT of the chest in patients with non-small cell lung cancer. Cancer Res 55 suppl (1995) 5759s-5763s
43. Grant S.C., Kostakoglu L., Kris M.G., et al. Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: a pilot trial. Eur J Nucl Med 23 (1996) 145-149
44. Schillaci O., Spanu A., and Madeddu G. [(99m)Tc]sestamibi and [(99m)Tc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors. Q J Nucl Med Mol Imaging 49 (2005) 133-144
45. Nosotti M., Santambrogio L., Gasparini M., et al. Role of 99mtc-hexakis-2-methoxy-isobutylisonitrile in the diagnosis and staging of lung cancer. Chest 122 (2002) 1361-1364
46. Schillaci O., Monteleone F., Volpino P., et al. Technetium-99m tetrofosmin single photon emission computed tomography in the evaluation of suspected lung cancer. Cancer Biother Radiopharm 14 (1999) 129-134
47. Buccheri G., Biggi A., Ferrigno D., et al. 99mTc-tetrofosmin scintigraphy in lung carcinoma staging and follow-up evaluations. Cancer 94 (2002) 1796-1807
48. Spanu A., Ginesu F., Pirica P., et al. The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions. Int J Oncol 22 (2003) 639-649
49. Kao C.H., Wang S.J., Lin W.J., et al. Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m mathoxy-isobutylisonitrile. Eur J Nucl Med 20 (1993) 249-254
50. Kao C.H., ChangLai S.P., Shen Y.Y., et al. Technetium-99m-tetrofosmin SPECT imaging of lung masses: a negative study. J Nucl Med 38 (1997) 1015-1019
51. Schillaci O., Danieli R., Manni C., et al. Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation?. Nucl Med Commun 25 (2004) 705-710
52. Ost D., Fein A.M., and Feinsilver S.H. Clinical practice. The solitary pulmonary nodule. N Engl J Med 348 (2003) 2535-2542
53. Minai O.A., Raja S., Mehta A.C., et al. Role of Tc-99m MIBI in the evaluation of single pulmonary nodules: a preliminary report. Thorax 55 (2000) 60-62
54. Spanu A., Schillaci O., Ginesu F., et al. 99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation. J Nucl Med 45 (2004) 376P (abstr)
55. Sergiacomi G., Schillaci O., Leporace M., et al. Integrated multislice CT and Tc-99m Sestamibi SPECT-CT evaluation of solitary pulmonary nodules. Radiol Med 111 (2006) 213-224
56. Mountain C.F. The international system for staging lung cancer. Semin Surg Oncol 18 (2000) 106-115
57. Friedman P.J. Lung cancer staging: efficacy of CT. (editorial). Radiology 182 (1992) 307-309
58. Chiti A., Maffioli L.S., Infante M., et al. Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT. J Nucl Med 37 (1996) 938-942
59. Schillaci O., Spanu A., Scopinaro F., et al. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT. J Nucl Med 44 (2003) 1219-1224
60. Shiun S.C., Sun S.S., Hsu N.Y., et al. Detecting mediastinal lymph node metastases in non-small-cell lung cancer using a combination of technetium-99m tetrofosmin chest single photon emission computed tomography and chest computed tomography. Cancer Invest 20 (2002) 311-317
61. Yellin A Zwas S.T., Rozenman J., et al. Experience with somatostatin receptor scintigraphy in the management of pulmonary carcinoid tumors. Isr Med Assoc J (2005) 712-716 2005 7
62. Fanti S., Farsad M., Battista G., et al. Somatostatin receptor scintigraphy for bronchial carcinoid follow-up. Clin Nucl Med 28 (2003) 548-552
63. Musi M., Carbone R.G., Bertocchi C., et al. Bronchial carcinoid tumours: a study on clinicopathological features and role of octreotide scintigraphy. Lung Cancer 22 (1998) 97-102
64. Kirsch C.M., von Pawel J., Grau I., et al. Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma. Eur J Nucl Med 21 (1994) 1318-1325
65. Reisenger I., Bohuslavitzki K.H., Brenner W., et al. Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study. J Nucl Med 39 (1998) 224-227
66. Kwekkeboom D.J., Kho G.S., Lamberts S.W.J., et al. The value of octreotide scntigraphy in patients with lung cancer. Eur J Nucl Med 21 (2004) 1106-1113
67. Krausz Y., Keidar Z., Kogan I., et al. SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol 59 (2003) 565-573
68. Tsagarakis S., Christoforaki M., Giannopoulou H., et al. A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing's syndrome. J Clin Endocrinol Metab 88 (2003) 4754-4758
69. Gambhir S.S., Shephard J.E., Handmaker H., et al. Analysis of the cost-effectiveness of a somatostatin analog-Tc99m- depreotide (Neotec) in the scintigraphic evaluation of solitary pulmonary nodules. J Nucl Med 40 (1999) 57P (abstr)
70. Blum J., Handmaker H., Lister-James J., et al. A multicenter trial with a somatostatin analog Tc-99m depreotide in the evaluation of solitary pulmonary nodules. Chest 117 (2000) 1232-1238
71. Halley A., Hugentobler A., Icard P., et al. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging 32 (2005) 1026-1032
72. Danielsson R., Bååth M., Svensson L., et al. Imaging of regional lymph node metastases with Tc-99m depreotide in patients with lung cancer. Eur J Nucl Med Mol Imaging 32 (2005) 925-931
73. Menda Y., and Kahn D. Somatostatin receptor imaging of non-small cell lung cancer with Tc-99m depreotide. Semin Nucl Med 32 (2002) 92-96
74. Israel O., and Krausz Y. SPECT/CT in tumour imaging. In: von Schulthess G.K. (Ed). Clinical Molecular Anatomic Imaging (2003), Lippincott Williams & Wilkins, Philadelphia 447-462
75. Front D., Israel O., Epelbaum R., et al. Ga-67 SPECT before and after treatment of lymphoma. Radiology 175 (1990) 515-551
76. Kaplan I.L., and Swayne L.C. Composite gallium SPECT/CT images in the evaluation of recurrent lymphoma. J Nucl Med 30 (1989) 874-875 (abstr)
77. Chajari M., Lacroix J., Peny A.M., et al. Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography?. Eur J Nucl Med 29 (2002) 380-387
78. Israel O., Yefremov N., Mor M., et al. A new technology of combined transmission (CT) and emission (Ga-67) tomography (TET) in the evaluation of patients with lymphoma. J Nucl Med 41 (2000) 70P (abstr)
79. Israel O., Yefremov N., Mor M., et al. Combined transmission Ga-67 emission tomography (TET) in the evaluation of response to treatment and diagnosis of recurrence in patients with lymphoma. Eur J Nucl Med 27 (2000) 1160 (abstr)
80. Sivolella S., Palumbo B., Palumbo I., et al. Usefulness of SPECT/CT with Ga-67 in evaluating patients with lymphoma. Q J Nucl Med Mol Imaging 48 (2004) 34 (abstr)
81. Palumbo B., Sivolella S., Palumbo I., et al. 67Ga-SPECT/CT with a hybrid system in the clinical management of lymphoma. Eur J Nucl Med Mol Imaging 32 (2005) 1011-1017
82. Carrera D., Bajen M.T., Mora J., et al. Clinical utility of fused 67GA SPECT/CT scan images in patients with lymphoma. Rev Esp Med Nucl 25 (2006) 3-9 (in Spanish)
83. Bar-Shalom R. Gallium SPECT/CT in lymphoma: the ups and downs of functional imaging. (editorial). Eur J Nucl Med Mol Imaging 32 (2005) 1247-1249
84. Sopov V., Yuzefovich I., Groshar D., et al. The effect of attenuation correction on lesion detection in 67Ga SPECT studies. J Nucl Med 43 (2002) 102P-103P (abstr)
85. Ferone D., Semino C., Boschetti M., et al. Initial staging of lymphoma with octreotide and other receptor imaging agents. Semin Nucl Med 35 (2005) 176-185
86. Erlandsson D., Visvikis D., Waddington W.A., et al. Improved activity quantification with a combined SPECT/CT system. Eur J Nucl Med Mol Imaging 29 (2002) S93 (abstr)
87. DeNardo G.L. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs). Semin Nucl Med 35 (2005) 202-211
88. Borghaei H., and Schilder R.J. Safety and efficacy of radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin). Semin Nucl Med 34 suppl 1 (2004) 4-9
89. Rao A.V., Akabani G., and Rizzieri D.A. Radioimmunotherapy for non-Hodgkin's lymphoma. Clin Med Res 3 (2005) 157-165
90. Juweid M.E. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice. J Nucl Med 43 (2002) 1507-1529
91. Macardle P.J., and Nicholson I.C. CD20. J Biol Regul Homeost Agents 16 (2002) 136-138
92. Wiseman G.A., Leigh B., Lamonica D., et al. Radiation dosimetry results for Zevalin radioimmunotherapy of rituximab-refractory non-Hodgkin lymphoma. Cancer 94 (2002) 1349-1357
93. Boucek J., and Turner J.H. Validation of prospective whole-body bone marrow dosimetry by SPECT/CT multimodality imaging in 131I-anti-CD20 rituximab radioimmunotherapy of non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging 32 (2005) 458-469
94. Koral K.F., Lin S., Fessler J.A., et al. Preliminary results from intensity-based CT-SPECT fusion in I-131 anti-B1 monoclonal-antibody therapy of lymphoma. Cancer suppl (1997) 2538-2544 15;80
95. Koral K.F., Li J., Dewaraja Y., et al. I-131 anti-B1 therapy/tracer uptake ratio using a new procedure for fusion of tracer images to computed tomography images. Clin Cancer Res 5 suppl (1999) 3004s-3009s
96. Koral K.F., Dewaraja Y., Li J., et al. Initial results for Hybrid SPECT-conjugate-view tumor dosimetry in 131I-anti-B1 antibody therapy of previously untreated patients with lymphoma. J Nucl Med 41 (2000) 1579-1586
97. Koral K.F., Dewaraja Y., Li J., et al. Update on hybrid conjugate-view SPECT tumor dosimetry and response in 131I-tositumomab therapy of previously untreated lymphoma patients. J Nucl Med 44 (2003) 457-464